These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12579177)

  • 1. Sight and comfort: complex procedures in end-stage Stevens-Johnson syndrome.
    Geerling G; Liu CS; Dart JK; Sieg P; Herold J; Collin JR
    Eye (Lond); 2003 Jan; 17(1):89-91. PubMed ID: 12579177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and maxillofacial surgeons' role in the first successful modified osteo-odonto-keratoprosthesis performed in the United States.
    Sawatari Y; Perez VL; Parel JM; Alfonso E; Falcinelli G; Falcinelli J; Marx RE
    J Oral Maxillofac Surg; 2011 Jun; 69(6):1750-6. PubMed ID: 21211883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical management of severe ocular surface disease].
    Stoiber J; Grabner G
    Klin Monbl Augenheilkd; 2005 Jul; 222(7):533-51. PubMed ID: 16034721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and gains of complex procedures to rehabilitate end stage ocular surface disease.
    Geerling G; Liu CS; Collin JR; Dart JK
    Br J Ophthalmol; 2002 Nov; 86(11):1220-1. PubMed ID: 12386071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal complications of modified osteo-odonto keratoprosthesis in chronic Stevens-Johnson syndrome.
    Basu S; Pillai VS; Sangwan VS
    Am J Ophthalmol; 2013 Nov; 156(5):867-873.e2. PubMed ID: 23958700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteo-odonto-keratoprosthesis - a maxillofacial perspective.
    Narayanan V; Nirvikalpa N; Rao SK
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e426-31. PubMed ID: 22425501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
    Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
    Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The osteo-odonto-keratoprosthesis (OOKP).
    Liu C; Paul B; Tandon R; Lee E; Fong K; Mavrikakis I; Herold J; Thorp S; Brittain P; Francis I; Ferrett C; Hull C; Lloyd A; Green D; Franklin V; Tighe B; Fukuda M; Hamada S
    Semin Ophthalmol; 2005; 20(2):113-28. PubMed ID: 16020351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use.
    Isawi H; Dhaliwal DK
    J Cataract Refract Surg; 2007 Sep; 33(9):1644-6. PubMed ID: 17720085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified osteo-odonto keratoprosthesis--the Indian experience--results of the first 50 cases.
    Iyer G; Pillai VS; Srinivasan B; Falcinelli G; Padmanabhan P; Guruswami S; Falcinelli G
    Cornea; 2010 Jul; 29(7):771-6. PubMed ID: 20489578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK.
    Liu C; Okera S; Tandon R; Herold J; Hull C; Thorp S
    Br J Ophthalmol; 2008 Sep; 92(9):1211-7. PubMed ID: 18511541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in south India.
    Kompella VB; Sangwan VS; Bansal AK; Garg P; Aasuri MK; Rao GN
    Indian J Ophthalmol; 2002 Dec; 50(4):283-6. PubMed ID: 12532492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Sequelae of Stevens-Johnson Syndrome: A Comprehensive Approach.
    Iyer G; Srinivasan B; Agarwal S
    Cornea; 2020 Nov; 39 Suppl 1():S3-S6. PubMed ID: 33031215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing the Ocular Surface for a Boston Keratoprosthesis Type 1 Through En Bloc Minor Salivary Gland Transplantation and Mucous Membrane Grafting in End-Stage Stevens-Johnson Syndrome.
    Arboleda A; Phansalkar R; Amescua G; Lee WS; Brandt JD; Mannis MJ; Kossler AL; Lin CC
    Cornea; 2023 Jul; 42(7):912-916. PubMed ID: 37159138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface, fornix, and eyelid rehabilitation in Boston type I keratoprosthesis patients with mucous membrane disease.
    Rootman DB; Kim MJ; Aldave AJ; Douglas R; Hwang C; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2015; 31(1):43-9. PubMed ID: 24911535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic cyclophotocoagulation in refractory glaucoma after osteo-odonto-keratoprosthesis in Stevens-Johnson syndrome: a case report.
    Forlini M; Adabache-Guel T; Bratu A; Rossini P; Mingaine MS; Cavallini GM; Forlini C
    Retin Cases Brief Rep; 2014; 8(3):193-6. PubMed ID: 25372436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoprosthesis: a 12-year follow-up.
    Girard LJ; Hawkins RS; Nieves R; Borodofsky T; Grant C
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1977; 83(2):252-67. PubMed ID: 878136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boston Type I Keratoprosthesis Implantation Following Autologous Submandibular Gland Transplantation for End Stage Ocular Surface Disorders.
    Gu J; Zhai J; Liao G; Chen J
    Ocul Immunol Inflamm; 2018; 26(3):452-455. PubMed ID: 27726460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.